A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 77
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : C3GN
Long Form : C3 glomerulonephritis
No. Year Title Co-occurring Abbreviation
2021 A case of C3 glomerulopathy with nephritis-associated plasmin receptor positivity without a history of streptococcal infection. C3G, NAPlr, PA
2021 C3 glomerulonephritis along with light chain proximal tubulopathy without crystal deposits in multiple myeloma: a case report. ---
2021 C3 glomerulonephritis and systemic lupus erythematosus: A report of a patient treated with eculizumab and review of the literature. Ig, SLE
2021 C3 glomerulonephritis associated with ANCA positivity: a case report. ANCAs, C3G, MN
2021 C3 Glomerulopathy, a pathology with scarce evidence. A case report. ---
2021 Clinico-pathological Profile and Outcome of C-3 Glomerulopathy in Indian Children. DDD
2021 Co-existence of Alport syndrome and C3 glomerulonephritis in a proband with family history. CFH
2021 Complete Renal Recovery in Pediatric Patient with C3 Glomerulonephritis: A Case Report. C3NeF
2021 Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry. C3G, IC-MPGN, MPGN
10  2021 Generation and Characterization of Mouse Models of C3 Glomerulonephritis With CFI D288G and P467S Mutations. AP, C3GP, LPS, SPF
11  2021 Long-term follow-up including extensive complement analysis of a pediatric C3 glomerulopathy cohort. C3G, C3NeFs, DDD, eGFR, sC5b-9
12  2020 A Narrative Review on C3 Glomerulopathy: A Rare Renal Disease. C3GP, DDD
13  2020 C3 Glomerulopathy: Pathogenesis and Treatment. C3G
14  2020 Concurrent anti-neutrophil cytoplasmic antibody-associated glomerulonephritis and IgG4-associated tubulointerstitial nephritis with C3 glomerulonephritis: A case report. ANCA, ANCA-GN, IgG4-RD, IgG4-TIN
15  2020 Function and Dysfunction of Complement Factor H During Formation of Lipid-Rich Deposits. AD, AMD, DDD
16  2020 Genetic and pathological findings in a boy with psoriasis and C3 glomerulonephritis: A case report and literature review. ---
17  2020 Infection-related Glomerulonephritis and C3 Glomerulonephritis - Similar Yet Dissimilar: A Case Report and Brief Review of Current Literature. AKI, GN, IF, IRGN, LUQ
18  2020 Long-term data on two sisters with C3GN due to an identical, homozygous CFH mutation and autoantibodies. CFH
19  2020 Pediatric C3 glomerulopathy: a 12-year single-center experience. C3G, DDD
20  2020 Therapy and outcomes of C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis. DDD, IC-MPGN
21  2020 Treatment of C3 Glomerulopathy in Adult Kidney Transplant Recipients: A Systematic Review. C3G, DDD, sMAC, TPE
22  2019 C3 Glomerulonephritis: A Rare Etiology of the Pulmonary Renal Syndrome. ---
23  2019 C3 glomerulopathy - understanding a rare complement-driven renal disease. DDD
24  2019 Clinicopathological features of C3 glomerulopathy in children: a single-center experience. C3G, CFH, DDD, EM
25  2019 Eculizumab in post-transplant C3 glomerulonephritis caused by a C3 mutation
. ---
26  2019 Glomerular C4d Staining Does Not Exclude a C3 Glomerulopathy. DDD
27  2019 Monoclonal immunoglobulin mediates complement activation in monoclonal gammopathy associated-C3 glomerulonephritis. C3NeF, CAP, MGRS, MGUS
28  2019 Poor allograft outcome in Indian patients with post-transplant C3 glomerulopathy. ACP, APFA, C3G, CFB, CFH, DDD
29  2018 A Case of Switch from C3 Glomerulonephritis to Proliferative Glomerulonephritis with Monoclonal IgG Deposits. MGP, PGNMID
30  2018 C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy. CKD, ESRD
31  2018 C3 glomerulonephritis and thrombotic microangiopathy of renal allograft after pulmonary infection in a male with concomitant two complement factor I gene variations: a case report. TMA
32  2018 C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab. ---
33  2018 Corticosteroid therapy alone for the treatment of C3 glomerulonephritis in association with monoclonal gammopathy
. eGFR
34  2018 Genetic analysis of the complement pathway in C3 glomerulopathy. DDD, MPGN
35  2018 Kidney Transplantation in C3 Glomerulopathy: A Case Series. C3G, DDD
36  2018 Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: change in treatment modality? A report of a case series. C3G, DDD, eGFR, ESRD, MPGN, RAAS
37  2018 Predictive factors for poor outcome in pediatric C3 glomerulonephritis. ESRD
38  2017 C3 glomerulonephritis with a severe crescentic phenotype. C3G, DDD
39  2017 Controlling the anaphylatoxin C5a in diseases requires a specifically targeted inhibition. aHUS
40  2017 Different types of glomerulonephritis associated with the dysregulation of the complement alternative pathway in 2 brothers: A case report. HUS, TMA
41  2017 High-dose melphalan and autologous hematopoietic stem cell transplant in patient with C3 glomerulonephritis associated with monoclonal gammopathy
. ASCT, MIg
42  2017 Mini review: A unique case of crescentic C3 glomerulonephritis. R-CHOP
43  2017 Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies. DDD, MPGN
44  2016 C3 glomerulonephritis in multiple myeloma: A case report and literature review. MM
45  2016 C3 glomerulopathy and current dilemmas. C3G, DDD
46  2016 C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome. AP, C3G, DDD
47  2016 Characterization of C3 in C3 glomerulopathy. C3G, DDD
48  2016 Concomitant Granulomatosis with Polyangiitis and C3 Glomerulonephritis Causing Renal Failure. GPA
49  2016 De novo C3 glomerulonephritis in a renal allograft. DDD
50  2016 Differences in clinical findings, pathology, and outcomes between C3 glomerulonephritis and membranoproliferative glomerulonephritis. IC-MPGN
51  2016 Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy. PIGN
52  2016 Severe active C3 glomerulonephritis triggered by immune complexes and inactivated after eculizumab therapy. MPGN
53  2015 A case of C3 glomerulonephritis successfully treated with eculizumab. ---
54  2015 C3 glomerulonephritis and autoimmune disease: more than a fortuitous association? ---
55  2015 Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience. C3GP, CFHR5, DDD, EM, IF
56  2015 Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis. C3G
57  2015 Familial C3 glomerulonephritis associated with mutations in the gene for complement factor B. CFB
58  2015 Likely Recurrence of C3 Glomerulonephritis in Kidney Transplantation: An Entity to Bear in Mind: Case Report. ---
59  2015 Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression. C3G
60  2014 C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis. C3G
61  2014 Complement factor H gene associations with end-stage kidney disease in African Americans. AAs, CFH, DDD, ESKD, IgAN, SKAT, SNP, T2D
62  2014 Defining the complement biomarker profile of C3 glomerulopathy. C3G, DDD
63  2014 Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children. MPGN
64  2013 A rare case: childhood-onset C3 glomerulonephritis due to homozygous factor H deficiency. ---
65  2013 C3 glomerulopathy. AP, C3NeF, CFH, DDD, GBM
66  2013 C3 glomerulopathy: clinicopathologic features and predictors of outcome. DDD
67  2013 C3 nephritic factor associated with C3 glomerulopathy in children. C3G, C3NeF, DDD
68  2013 Clinical findings, pathology, and outcomes of C3GN after kidney transplantation. ---
69  2013 Complement factor H related proteins (CFHRs). aHUS, AMD, CFHRs, DDD, SLE
70  2013 Eculizumab and recurrent C3 glomerulonephritis. C3G, DDD, sMAC
71  2013 Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases. aHUS, AMR, C3G, DDD
72  2013 Molecular genetics of familial hematuric diseases. ESKD, GBM, GFND, TBMN
73  2013 Recent insights into C3 glomerulopathy. AP, DDD, GN
74  2013 Recovery of renal function succeeding stem cell transplant: a case of C3 Glomerulonephiritis secondary to monoclonal gammopathy. MPGN
75  2013 Soluble CR1 therapy improves complement regulation in C3 glomerulopathy. DDD
76  2012 C3 glomerulonephritis and CFHR5 nephropathy. CFHR5
77  2012 C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. AP